- Home
- MAX vs CRMD Comparison
MAX vs CRMD Comparison
Compare MAX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- CRMD
- Stock Information
- Founded
- MAX 2014
- CRMD 2006
- Country
- MAX United States
- CRMD United States
- Employees
- MAX N/A
- CRMD N/A
- Industry
- MAX Industrial Machinery/Components
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- MAX Industrials
- CRMD Health Care
- Exchange
- MAX Nasdaq
- CRMD Nasdaq
- Market Cap
- MAX 613.7M
- CRMD 738.4M
- IPO Year
- MAX 2020
- CRMD 2010
- Fundamental
- Price
- MAX $10.97
- CRMD $12.42
- Analyst Decision
- MAX Buy
- CRMD Strong Buy
- Analyst Count
- MAX 8
- CRMD 6
- Target Price
- MAX $22.00
- CRMD $15.67
- AVG Volume (30 Days)
- MAX 440.0K
- CRMD 1.3M
- Earning Date
- MAX 02-18-2025
- CRMD 03-11-2025
- Dividend Yield
- MAX N/A
- CRMD N/A
- EPS Growth
- MAX N/A
- CRMD N/A
- EPS
- MAX 0.19
- CRMD N/A
- Revenue
- MAX $681,230,000.00
- CRMD $12,262,234.00
- Revenue This Year
- MAX $124.41
- CRMD N/A
- Revenue Next Year
- MAX $31.11
- CRMD $246.41
- P/E Ratio
- MAX $58.21
- CRMD N/A
- Revenue Growth
- MAX 72.47
- CRMD 41184.20
- 52 Week Low
- MAX $10.21
- CRMD $2.89
- 52 Week High
- MAX $25.78
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- MAX 44.56
- CRMD 69.24
- Support Level
- MAX $10.63
- CRMD $11.90
- Resistance Level
- MAX $11.45
- CRMD $13.09
- Average True Range (ATR)
- MAX 0.45
- CRMD 0.75
- MACD
- MAX 0.04
- CRMD 0.26
- Stochastic Oscillator
- MAX 44.66
- CRMD 87.07
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.